14. Epigenetic Targets and Drug Development
- Antonio Giordano4,5,6,
- Marcella Macaluso4
Published Online: 3 JUN 2011
DOI: 10.1002/9781118005743.ch14
Copyright © 2011 Wiley-Blackwell.
Book Title

Cancer Epigenetics: Biomolecular Therapeutics for Human Cancer
Additional Information
How to Cite
Vogiatzi, P., Scarano, M. I. and Claudio, P. P. (2011) Epigenetic Targets and Drug Development, in Cancer Epigenetics: Biomolecular Therapeutics for Human Cancer (eds A. Giordano and M. Macaluso), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118005743.ch14
Editor Information
- 4
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA
- 5
Department of Human Pathology and Oncology, University of Siena, Siena, Italy
- 6
Oncology Research Centre of Mercogliano (CROM), Avellino, Italy
Publication History
- Published Online: 3 JUN 2011
- Published Print: 27 JUN 2011
ISBN Information
Print ISBN: 9780471710967
Online ISBN: 9781118005743
- Summary
- Chapter
- References
Keywords:
- epigenetic targets and drug development - epigenetic events, gene function, selectively activated or inactivated;
- RNA interference, evolutionarily conserved mechanism - of posttranscriptional gene silencing;
- epigenetic drugs, and potential pitfalls - nucleoside analog inhibitors, reactivating silenced genes inhibiting DNA methylation toxicity
Summary
This chapter contains sections titled:
Epigenetics: Basic Mechanisms of the Changing Image of the Gene
Current Epigenetic Interventions in Therapy
DNA Methylation Inhibitors
RNA Interference
Histone Deacetylase Inhibitors
The Potential Pitfalls of Epigenetic Drugs
References
